Your browser does not support JavaScript! before use docindia please enable Javascript on your browser

YYBA (as PLD) - WELMATE - URINARY PAIN RELIEF (73581-909)


OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Phenazopyridine Hydrochloride 99.5 mg


OTC - PURPOSE SECTION

Purpose

Urinary Tract Analgesic


OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.In case of an overdose, get medical help or contact poison Control Center right away.


INDICATIONS & USAGE SECTION

UseRelief from urinary pain, burning, urgency and frequency associated with urinary tract infections.


WARNINGS SECTION

Please read insert for important precautions.

Ask a doctor before use if you have:

■ kidney disease

■ allergies to foods, preservatives or dyes

■ had a hypersensitive reaction to Phenazopyridine Hydrochloride

Do not useif you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

When using this product

■ stomach upset may occur, taking this product with or after meals may reduce stomach upset

■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

Stop use and ask a doctor if

■ your symptoms last for more than 2 days

■ you suspect you are having an adverse reaction to the medication

■ Long-term adminitration of phenazopyridine hydrochloride has induced neoplasia in rats (large instestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human enoplasia has beeen reported, adequate epidemiological studies along these lines have not been conducted.

If pregnant or breast-feeding,ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.

Keep out of reach of children.In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.


OTHER SAFETY INFORMATION

■ This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests

■ This product may stain contact lenses and other items if handled after touching tablets

■ long term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted

■ Store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light


DOSAGE & ADMINISTRATION SECTION

■Adults and children 12 years of age and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor

■ Children under 12: Do not use wihout consulting a doctor


INACTIVE INGREDIENT SECTION

pregelatinized starch, microcrystalline cellulose, maize (corn) starch, povidone, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxypropyl methylcellulose, polyethylene glycol


OTC - QUESTIONS SECTION

call toll-free 1-845-547-2667


SPL UNCLASSIFIED SECTION

Size and color of tablets may vary.

*This product is not manufactured or distributed by the owner of the registered trademark AZO Urinary Pain Relief®.

Distributed by: Wellspring

Airmont, NY 10952, USA


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL